Teva, Units Held Liable for Fueling N.Y. Opioid Crisis

  • Panel found Teva’s opioid marketing caused public nuisance
  • Judge will decide later on compensation for state, counties

Teva Pharmaceutical Industries’ headquarters in Jerusalem, Israel.

Photographer: Adam Reynolds/Bloomberg

Lock
This article is for subscribers only.

New York jurors concluded Teva Pharmaceutical Industries and some of its units helped create a public-health crisis through their marketing and distribution of opioid painkillers across the state, in the pharma industry’s latest loss in the sprawling litigation over the highly addictive drugs.

The Israel-based firm now faces potentially billions of dollars in compensation claims from the state and two Long Island counties accusing Teva executives of flooding their areas with more than a billion opioids pills over nearly a decade and using misleading tactics to sell them.